Features of MRI of the prostate gland when planning targeted biopsy with combined ultrasound and magnetic resonance imaging control
- Autores: Burulev A.1, Itskovich I.1, Kakheli M.1
-
Afiliações:
- North-Western State Medical University named after I.I. Mechnikov
- Edição: Volume 2, Nº 1S (2021)
- Páginas: 16-17
- Seção: Articles
- URL: https://journals.rcsi.science/DD/article/view/70252
- DOI: https://doi.org/10.17816/DD20211s16
- ID: 70252
Citar
Texto integral
Resumo
.
Texto integral
##article.viewOnOriginalSite##Sobre autores
A. Burulev
North-Western State Medical University named after I.I. Mechnikov
Autor responsável pela correspondência
Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015
I. Itskovich
North-Western State Medical University named after I.I. Mechnikov
Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015
M. Kakheli
North-Western State Medical University named after I.I. Mechnikov
Email: artmed@mail.ru
Rússia, 41, Kirochnaya street, Saint Petersburg, 191015
Bibliografia
- Zyryanov AV, Popov IB, Ponomarev AV, et al. Targeted prostate biopsy under MRI control (fusion). Academic journal of West Siberia. 2016;12(4):28–30. (In Russ).
- Rosenkrantz AB, Verma S, Choyke P., et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: a consensus statement by AUA and SAR. J Urol. 2016;196(6):1613–1618. doi: 10.1016/j.juro.2016.06.079
- De Gorski A, Mozer P, Roupret M, et al. En cas de premiere serie de biopsies de prostate, les biopsies prostatiques ciblees par voie transrectale avec fusion echo/IRM ont un meilleur rendement que les biopsies standard pour la detection de cancer significatif dans les prostates > 40 mL. Progres en Urologie. 2014;24(13):813. doi: 10.1016/j.purol.2014.08.068
![](/img/style/loading.gif)